All AbMole products are for research use only, cannot be used for human consumption.
(+)-JQ1 is a BET bromodomain inhibitor that acts on BRD4(2) with an IC50 of 33 nM and binds to all bromodomain domains in the BET family, but not to bromodomain domains outside the BET family. JQ1 down-regulates CD47 expression through a C-MYC-mediated pathway, and JQ1 down-regulates CD47 expression through a C-MYC-mediated pathway.way.
Nat Commun. 2024 Jul 17;15(1):5994.
ARID1A safeguards the canalization of the cell fate decision during osteoclastogenesis
(+)-JQ1 purchased from AbMole
Proc Natl Acad Sci U S A. 2024 Apr 30;121(18).
Liver cancer development driven by the AP-1/c-Jun˜Fra-2 dimer through c-Myc
(+)-JQ1 purchased from AbMole
Tissue Cell. 2024 Aug 23;91:102531.
BRD4 absence inactivates endoplasmic reticulum stress to retard dehydroepiandrosterone-triggered ovarian granular cell apoptosis in polycystic ovary syndrome via GRP78
(+)-JQ1 purchased from AbMole
Nat Commun. 2023 Mar 14;14(1):1413.
BRD9-mediated chromatin remodeling suppresses osteoclastogenesis through negative feedback mechanism
(+)-JQ1 purchased from AbMole
J Exp Med. 2022 Nov 7;219(11):e20212405.
Transit-amplifying cells control R-spondins in the mouse crypt to modulate intestinal stem cell proliferation
(+)-JQ1 purchased from AbMole
JCI Insight. 2022 Sep 8;7(17):e151851.
Targeting ESR1 mutation-induced transcriptional addiction in breast cancer with BET inhibition
(+)-JQ1 purchased from AbMole
Cancer Cell. 2016 Aug 8;30(2):290-307.
Regulation of OGT by URI in Response to Glucose Confers c-MYC-Dependent Survival Mechanisms
(+)-JQ1 purchased from AbMole
Oncotarget. 2015 Nov 10;6(35):37410-25.
SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells
(+)-JQ1 purchased from AbMole
Cell Experiment | |
---|---|
Cell lines | MM.1S, RPMI-8226, KMS-20, L-363 Dox40 and AMO-1 cell lines |
Preparation method | Cell Viability Assays MM cell lines were seeded onto 384-well tissue culture treated plates at a density of 1,000 cells/well in a volume of 50 µL of media. After seeding cells were incubated for 1 hour and during the interim a stock plate of JQ1 was thawed at room temperature in a desiccated box. The addition of JQ1 to the assay plate was done with disposable 384-well pins (V&P Scientific, San Diego, CA) that delivered 100 nL of the drug diluted in DMSO to each well of the plate. After 72 hours of incubation cells were analyzed for cell viability by the addition of CellTiter Glo (Promega, Madison, WI) to the assay plates. After 30 min incubation at 37 oC the signal from the viable cells was analyzed on a Luminoskan luminometer (Labsystems Franklin, MA). |
Concentrations | 0~1µM |
Incubation time | 72 h |
Animal Experiment | |
---|---|
Animal models | SCID-beige mice orthotopically xenografted after intravenous injection with MM.1S-luc+ cells |
Formulation | JQ1 in 10% cyclodextrine |
Dosages | 50 mg/kg daily |
Administration | intra-peritoneally for 5 days/week, 2 weeks |
Molecular Weight | 456.99 |
Formula | C23H25ClN4O2S |
CAS Number | 1268524-70-4 |
Solubility (25°C) | DMSO 45 mg/mL Ethanol 45 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[2] Matzuk MM, et al. Cell. Small-molecule inhibition of BRDT for male contraception.
[3] Delmore JE, et al. Cell. BET bromodomain inhibition as a therapeutic strategy to target c-Myc.
[4] Filippakopoulos P, et al. Nature. Selective inhibition of BET bromodomains.
Related Epigenetic Reader Domain Products |
---|
dBRD9 dihydrochloride
dBRD9 dihydrochloride is a selective BRD9 PROTAC degrader. |
BBC0403
BBC0403 is a selective BRD2 inhibitor with Kds of 7.64 μM and 41.37 μM for BRD2 (BD2) and BRD2 (BD1), respectively. |
BAY-155
BAY-155 is a potent and selective menin-MLL tool inhibitor, with an IC50 of 8 nM. |
FHT-1015
FHT-1015 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with IC50s of ≤10 nM. |
ISOX-DUAL
ISOX-DUAL is a dual CBP/BRD4 inhibitor with IC50 values of 0.65 μM and 1.5 μM for CBP and BRD4, respectively. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.